603387 基蛋生物
2024/03 - 三个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)3.30511.09821.74420.23117.600
总资产报酬率 ROA (%)2.2767.51014.63813.66912.946
投入资产回报率 ROIC (%)2.5888.65116.94515.95613.240

边际利润分析
销售毛利率 (%)71.47567.42165.06965.58063.030
营业利润率 (%)31.23122.39230.91632.30333.649
息税前利润/营业总收入 (%)28.78118.59428.99631.99533.243
净利润/营业总收入 (%)27.19020.74827.66129.39429.405

收益指标分析
经营活动净收益/利润总额(%)100.83294.241101.44592.78185.376
价值变动净收益/利润总额(%)0.0628.4386.1645.21711.373
营业外收支净额/利润总额(%)-0.377-0.540-0.585-0.256-1.058

偿债能力分析
流动比率 (X)2.2172.2002.5042.9083.224
速动比率 (X)1.9681.9652.2232.5982.901
资产负债率 (%)25.43827.31927.57127.53125.776
带息债务/全部投入资本 (%)19.55920.70320.11021.571--
股东权益/带息债务 (%)403.385375.312388.934359.711428.398
股东权益/负债合计 (%)274.599248.386244.750243.824264.099
利息保障倍数 (X)-12.340-5.055-16.660-142.038-616.951

营运能力分析
应收账款周转天数 (天)125.590123.43192.161114.9910.000
存货周转天数 (天)223.818201.398147.557173.2210.000